ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

PHAT Phathom Pharmaceuticals Inc

10,60
0,92 (9,50%)
07 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Phathom Pharmaceuticals Inc PHAT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,92 9,50% 10,60 18:46:21
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
9,60 9,60 10,77 10,60 9,68
mais cotações »

Notícias Recentes

Data Hora Fonte Título
28/05/202409:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
15/05/202409:00GLOBEPhathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan)..
09/05/202409:00GLOBEPhathom Pharmaceuticals Reports First Quarter 2024 Financial..
29/04/202409:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/04/202409:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/03/202409:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
07/03/202410:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29/02/202410:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13/02/202410:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31/01/202410:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
14/12/202310:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06/12/202310:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28/11/202310:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
09/11/202310:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
01/11/202318:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
01/11/202318:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202309:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202309:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/09/202309:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/09/202309:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/08/202309:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
10/08/202309:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
12/06/202310:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
12/06/202309:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..

Seu Histórico Recente

Delayed Upgrade Clock